BenzingaAugust 18, 2026 at 6:56 AM NY17 days ago
Xylem Affirms FY2026 Adj EPS Guidance of $5.55-$5.70 vs $5.54 Est; Affirms FY2026 Sales Guidance of $9.200B vs $9.254B Est
Xylem (NYSE:XYL) affirms FY2026 Adj EPS guidance from $5.55-$5.70 to $5.55-$5.70 vs $5.54 analyst estimate. Affirms FY2026 sales outlook from $9.200 billion to $9.200 billion vs $9.254 billion estimate.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site — Benzinga
Companies in This Story
Related Stories
Which dow jones stocks are moving on Friday?
ChartMill3 hours ago
Exploring the top movers within the S&P500 index during today's session.
ChartMill3 hours ago
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo3 hours ago
Sector Update: Financial
Yahoo4 hours ago
Should You Buy, Sell or Hold PVH Stock Post Q2 Earnings?
Yahoo5 hours ago